medigraphic.com

2002, Number S1

<< Back Next >>

Arch Cardiol Mex 2002; 72 (S1)

Medical therapy for the surviving patient of a severe myocardial infarction without symptoms

Lacy NMC

Language: Spanish
References: 22
Page: 100-105
PDF size: 65.86 Kb.


ABSTRACT

Most patients that survive an acute myocardial infarction remain symptomatic, mainly with manifestations of heart failure, arrhythmias, or residual ischemia; however there is a group of patients without symptoms that must be studied because their evolution could be life threatening, specially if they have left ventricular dysfunction, arrhythmias, severe coronary artery disease, comorbid diseases, are older patients or have history of previous myocardial infarctions. An exercise treadmill test must be done as well as Holter monitoring, radionuclide perfusion imagining echocardiography with or without drugs, nuclear magnetic resonance and cardiac catheterization with coronary angiography to determine pharmacologic treatment and prompt revascularization.


REFERENCES

  1. ACC/AHA Guidelines for the management of patients with myocardial infarction. J Am Coll Cardiol 1999; 34: 890-911.

  2. Fisher A, gutstein DE, Fuster V: Thrombosis and coagulation abnormalities in the acute coronary syndromes. Cardiology Clinics 1999; 17(2): 283-294.

  3. Shah PK: Plaque disruption and thrombosis. Cardiology Clinics 1999; 17(2): 271-281.

  4. Kim RJ, Wu E, Allen R, Chen EL, Parker MA, Simonetti O, et al: The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000; 343: 1445-53.

  5. Morrow DA, Antman EM, Chalesworth A, Braunwald E: TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score, for risk assessment at presentation. Circulation 2000; 102: 2031-7.

  6. Kuri J, Martínez-Sánchez C, Moreno M, Clemente A, Virgos A, Fernández de la Vega P: Prueba de esfuerzo de bajo nivel en la fase temprana del infarto del miocardio y su correlación con la coronariografía. Arch Inst Cardiol Mex 1989; 59: 279-286.

  7. Thirmann DR, Corech J, Schulman SP: Lack of benefit for intravenous thrombolysis in patients with myocardial infarction who are older than 75 years. Circulation 2000; 101: 2239-2246.

  8. Ross AM, Coyne KS, Moreyra E: For the GUSTO-1 angiographic investigators. Extended mortality benefit of early post-infarction reperfusion. Circulation 1998; 97: 1549-56.

  9. Gibson CM, Cannon CP, Murphy SA: For the TIMI (Thrombolysis In Myocardial Infarction ) study group: Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Circulation 2000; 101: 125-30.

  10. Nunn CM, O’neill WW, Rothbaum D, Stone GW, O’keefe J, Overlie P, et al: Long-term outcome after primary angioplasty in myocardial infarction (PAMI-I) Trial. J Am Coll Cardiol 1999; 33: 640-46.

  11. Grines CL, Cox DA, Stone GW: Coronary angioplasty with or without stent implantation for acute myocardial infarction. N Engl J Med 1999; 341: 489-56.

  12. Hochman JS, Sleeper LA, White hd, Dzavik V, Wong SC, Menon V, et al: One year survival following early revascularization for cardiogenic shock. JAMA 2001; 285: 190-92.

  13. Hennekens CH, Albert CM, Godfried SL: Adjunctive drug therapy of acute myocardial infarction-evidence from clinical trials. N Engl J Med 1996; 335: 1660-7.

  14. Roberts R, Roger WJ, Mueller HS, Lambrew CT, Diver DJ, Smith HC, et al: Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction: results of the thrombolysis in myocardial infarction (TIMI) II-B-Study. Circulation 1991; 83: 422-37.

  15. The norwegian multicenter study group. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med 1981; 304: 801-7.

  16. Beta-blocker heart attack trial research group. A randomized trial of propranolol in patients with acute myocardial infarction: mortality results. JAMA 1982; 247: 1707-7.

  17. The acute infarction ramipril efficacy (AIRE) Study investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993; 342: 821-28.

  18. Flather MD, Yusuf S, Køber L, Pfeffer M, Hall A, Murray G, et al: Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. Lancet 2000; 355: 1575-81.

  19. Scandinavian simvastatin survival study group. Baseline serum cholesterol and treatment effect in the Scandinavian simvastatin survival group study (4S). Lancet 1995; 345: 1274-5.

  20. Ross SD, Allen IE, Connelly JE, Korenblat BM, Smith ME, Bishop D: Clinical outcomes in statin treatment trials: a meta-analysis. Arch Intern Med 1999; 159: 1793-1802.

  21. Jones P, Kafonek S, Laurora I, Hunninhake D: For the CURVES investigators: Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study). Am J Cardiol 1998; 81: 582-587.

  22. Fletcher GF: How to implement physical activity in primary and secondary prevention- A statement for healthcare professionals from the task force on risk reduction. Circulation 1997; 96: 355-7.




2020     |     www.medigraphic.com